4//SEC Filing
GARNICK ROBERT L 4
Accession 0001683168-22-001212
CIK 0000836564other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 8:00 PM ET
Size
7.2 KB
Accession
0001683168-22-001212
Insider Transaction Report
Form 4
GARNICK ROBERT L
Director
Transactions
- Other
Convertible Note
2022-02-18$50000.00/sh→ See footnotes
Footnotes (3)
- [F1]The Convertible Notes were issued on February 18, 2022 in exchange of $50,000 in proceeds to the Company; have no stated maturity date or expiration date; bear interest at a simple rate equal to eight percent (8.0%) per annum until converted; and automatically convert into the same equity securities offered in the Qualified Financing (see footnote 2 and 3) or at the option of the holder into the same equity securities offered in a Smaller Financing (see footnote 2 and 3).
- [F2]Upon a Qualified Financing or Smaller Financing (see footnote 3), the conversion price shall be equal to the lower of (i) the product equal to 80% times the lowest per unit purchase price of the equity securities issued for cash in the Qualified Financing or Smaller Financing (representing a 20% discount), or (ii) $1.00.
- [F3]A Qualified Financing represents a single transaction or series or transactions whereby the Company receives aggregate gross proceeds of at least $5 million from the sale of equity securities following the issuance date of the Convertible Note (excluding proceeds from the issuance of any future Convertible Notes). A Smaller Financing represents any sale of equity securities whereby the aggregate gross proceeds are less than $5 million (excluding proceeds from the issuance of any future Convertible Notes).
Documents
Issuer
Mosaic ImmunoEngineering Inc.
CIK 0000836564
Entity typeother
Related Parties
1- filerCIK 0001214124
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 8:00 PM ET
- Size
- 7.2 KB